Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy

References

• KesslerRCAngermeyerMAnthonyJCLifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey InitiativeWorld Psychiatry20076316817618188442
   PubMed Web of Science ®Google Scholar
• MuellerTILeonACKellerMBRecurrence after recovery from major depressive disorder during 15 years of observational follow-upAm J Psychiatry199915671000100610.1176/ajp.156.7.100010401442
   PubMed Web of Science ®Google Scholar
• BrometEAndradeLHHwangICross-national epidemiology of DSM-IV major depressive episodeBMC Med201199010.1186/1741-7015-9-9021791035
   PubMed Web of Science ®Google Scholar
• de GraafRTuithofMvan DorsselaerSten HaveMComparing the effects on work performance of mental and physical disordersSoc Psychiatry Psychiatr Epidemiol201247111873188310.1007/s00127-012-0496-722434047
   PubMed Web of Science ®Google Scholar
• EkmanMGranströmOOmérovSJacobJLandénMThe societal cost of depression: evidence from 10,000 Swedish patients in psychiatric careJ Affect Disord2013150379079710.1016/j.jad.2013.03.00323611536
   PubMed Web of Science ®Google Scholar
• FonsekaTMMacQueenGMKennedySHNeuroimaging biomark-ers as predictors of treatment outcome in major depressive disorderJ Affect Disord2018233213510.1016/j.jad.2017.10.04929150145
   PubMed Web of Science ®Google Scholar
• MöllerHJStandardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scalesWorld J Biol Psychiatry200910162610.1080/1562297080226460618663668
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• FrankEPrienRFJarrettRBConceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrenceArch Gen Psychiatry19914898518551929776
   PubMed Web of Science ®Google Scholar
• MillerIWKeitnerGISchatzbergAFThe treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramineJ Clin Psychiatry199859116086199862607
   PubMed Web of Science ®Google Scholar
• PapakostasGIPetersenTDenningerJWPsychosocial functioning during the treatment of major depressive disorder with fluoxetineJ Clin Psychopharmacol200424550751115349006
   PubMed Web of Science ®Google Scholar
• HirschfeldRMDunnerDLKeitnerGDoes psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationBiol Psychiatry200251212313311822991
   PubMed Web of Science ®Google Scholar
• van der VoortTYSeldenrijkAvan MeijelBFunctional versus syndromal recovery in patients with major depressive disorder and bipolar disorderJ Clin Psychiatry2015766e809e81410.4088/JCP.14m0954826132690
   PubMed Web of Science ®Google Scholar
• ZimmermanMMcGlincheyJBPosternakMAFriedmanMBoerescuDAttiullahNDiscordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be definedPsychiatry Res2006141218519110.1016/j.psychres.2005.05.01616499976
   PubMed Web of Science ®Google Scholar
• ZimmermanMMartinezJAAttiullahNWhy do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?J Clin Psychiatry201273679079510.4088/JCP.11m07203.22569085
   PubMed Web of Science ®Google Scholar
• BortolatoBMiskowiakKWKöhlerCACognitive remission: a novel objective for the treatment of major depression?BMC Med201614910.1186/s12916-016-0560-326801406
   PubMed Web of Science ®Google Scholar
• BrnabicALinCMonkulESDueñasHRaskinJMajor depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studiesCurr Med Res Opin201228121891189710.1185/03007995.2012.74865423145858
   PubMed Web of Science ®Google Scholar
• HaradaESatoiYKikuchiTWatanabeKAlevLMimuraMResidual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depressionNeuropsychiatr Dis Treat2016121599160727418827
   PubMed Web of Science ®Google Scholar
• HaradaESatoiYKugaAAssociations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational studyNeuropsychiatr Dis Treat2017132437244510.2147/NDT.S13456629033569
   PubMed Web of Science ®Google Scholar
• KugaATsujiTHayashiSAn observational study of dulox-etine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysisNeuropsychiatr Dis Treat2017132105211410.2147/NDT.S13143828831259
   PubMed Web of Science ®Google Scholar
• KugaATsujiTHayashiSAn observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of lifeNeuropsychiatr Dis Treat2017132115212410.2147/NDT.S13644828831260
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders4th ed Text RevisonWashington (DC)American Psychiatric Association2000
   Google Scholar
• RushAJTrivediMHIbrahimHMThe 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
   PubMed Web of Science ®Google Scholar
• CleelandCSRyanKMPain assessment: global use of the brief pain inventoryAnn Acad Med Singapore19942321291388080219
   PubMedGoogle Scholar
• Ministry of Health, Labor, and WelfareGood Post-Marketing Study Practices Ordinance No. 171 issued on December 202004
   Google Scholar
• RomeraIPérezVMenchónJMPolaviejaPGilaberteIOptimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioningPsychiatry Res2011186113313710.1016/j.psychres.2010.06.02320659770
   PubMed Web of Science ®Google Scholar
• SawamuraJIshigookaJNishimuraKRe-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing studyHealth Qual Life Outcomes20181611410.1186/s12955-018-0838-629338728
   PubMed Web of Science ®Google Scholar
• de VriesGKoeterMWNieuwenhuijsenKHeesHLScheneAHPredictors of impaired work functioning in employees with major depression in remissionJ Affect Disord201518518018710.1016/j.jad.2015.07.01326188379
   PubMed Web of Science ®Google Scholar
• TrivediMHMorrisDWWisniewskiSRIncrease in work productivity of depressed individuals with improvement in depressive symptom severityAm J Psychiatry2013170663364110.1176/appi.ajp.2012.1202025023558394
   PubMed Web of Science ®Google Scholar
• KishiTMatsudaYMukaiTA cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophreniaCompr Psychiatry201559919710.1016/j.comppsych.2015.02.00425724075
   PubMed Web of Science ®Google Scholar
• FurukawaTATakeuchiHHiroeTSymptomatic recovery and social functioning in major depressionActa Psychiatr Scand2001103425726111328238
   PubMed Web of Science ®Google Scholar
• SheehanDVNakagomeKAsamiYPappadopulosEABoucherMRestoring function in major depressive disorder: a systematic reviewJ Affect Disord201721529931310.1016/j.jad.2017.02.029.28364701
   PubMed Web of Science ®Google Scholar
• MartinezJMKatonWGreistJHA pragmatic 12-week, ran-domized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episodeInt Clin Psychopharmacol2012271172610.1097/YIC.0b013e32834ce11b22027844
   PubMed Web of Science ®Google Scholar
• DetkeMJWiltseCGMallinckrodtCHMcNamaraRKDemitrackMABitterIDuloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trialEur Neuropsychopharmacol200414645747010.1016/j.euroneuro.2004.01.00215589385
   PubMed Web of Science ®Google Scholar
• PapakostasGINelsonJCKasperSMöllerHJA meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorderEur Neuropsychopharmacol200818212212710.1016/j.euroneuro.2007.07.00517719752
   PubMed Web of Science ®Google Scholar